Paying particular emphasis on prevention, early detection and treatment of breast cancer and other mammological diseases, EVZOIA in cooperation with Euromedica Geniki Kliniki Thessaloniki, have created the Model Breast Center mymastos.gr.

Today, we all know that…

Breast cancer is the most common form of cancer that occurs in women.
In her lifetime, 1 out of 8 women will develop breast cancer.
In Greece, it is estimated that 4.500 new cases of breast cancer are documented each year.
Early and complete diagnosis and more substantial protection, is the duty of every modern woman.
Breast cancer is treated successfully if diagnosed early.

The integrated diagnostic breast screening process of the Model Breast Center, includes

Digital mammography is the examination of choice, for the prevention and diagnosis of breast diseases. It has the ability to show us potential problems, prior to presenting clinical symptoms. For this reason, it is the prefered examination in preventive testing for breast cancer, with two images for each breast. A crown rump (CC) and an oblique (MLO). When further diagnostic testing is required, additional mammographic images are taken, such as magnifying, localizing, purely lateral etc.

An annual mammography test for women from the age of 40, or depending on their medical history, from the age that the specialist doctor considers to be the recommended.

The ultrasound examination of the breast has no radiation and is used complementary to preventive and diagnostic breast tests. It supplements digital mammography, clarifying its findings (increased sensitivity), analyzing the superimposing of tissues, or highlighting the pathology of the examined area.

In cases of women with denser breasts, where the sensitivity of mammography is low, it can provide us with valuable clinical information.

It is a useful diagnostic tool, which in the presence of indications can help us complement the mammography and ultrasound.

It is increasingly frequently used in preventive tests – screening:

• of dense breasts,
• of post operation breasts,
• in the existence of breast implants,

But also in diagnostic tests:

• to exclude the multifocal existence of malignancy
• to pinpoint the primary site
• suspicious lymphadenopathy etc.

Clinical examination is the basic diagnostic approach for breast diseases.

It is performed by a qualified surgeon who after assessing the record (history), clinical examination and  radiological examinations (mammography, ultrasound), will approach each problem in a diagnostic manner.

The Breast Pap Halo Test is addressed to women of 25 plus years of age, who are not yet being subjected to mammographies. In cases with strained family history, the examination is recommended from the age of 18 years. The Breast Pap Halo Test is approved since 2007 by the American Food and Drug Administration (FDA) and since 2008 by the European Union (CE mark).

The Breast Pap HALO Test is a non invasive, completely non traumatic, harmless, well tolerated and without any radiation, fluid collection method from the milk ducts, which are considered the point of development of most cancers (95%). Through this collection, the risk of cancer appearance is assessed seven to eight years before it is developed and identified in the mammography.

The test’s duration is approximately 5 minutes and is not painful. It is done with the use of  latest technology medical equipment, without any trouble for the examined and is notably affordable.

It is recommended to be conducted yearly.

In many cases it is considered necessary to obtain tissue for cytological or histological examinations, from a suspicious area.

FNA, through a thin needle cytological tissue is obtained (Cytology laboratory).

CORE, through a cutter needle under local anesthesia, tissue is obtained (Pathologoanatomic laboratory).

There are many ways of conducting a biopsy

1. Guided by a mammogram
2. Guided by an ultrasound
3. Guided by an MRI scanner
4. Surgical biopsy by removing part of the lesion and histological examination (to abolition)

Preoperative

• With a transdermal wire -HOOK WIRE
• With dermographism

Prior to chemotherapy or after biopsy

By introducing inside the lesion, special radiopaque markings, usually made of titanium, so as to detect the suspicious region more easily, at a later time.